Showing results (221-230 of 318) with videos related to
Sort By:
Pageof 32
Breast (Edinburgh, Scotland)|March 7, 2013
Gene expression profiling in breast cancer: a clinical perspectiveGrazia Arpino, Daniele Generali, Anna Sapino, et al.Antibiotics (Basel, Switzerland)|October 25, 2024
Beneficial Effects Induced by a Proprietary Blend of a New Bromelain-Based Polyenzymatic Complex Plus N-Acetylcysteine in Urinary Tract Infections: Results from In Vitro and Ex Vivo StudiesLucia Recinella, Morena Pinti, Maria Loreta Libero, et al.Scientific Reports|July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving OlaparibFrancesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.British Journal of Cancer|November 2, 2016
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patientsMatteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, et al.Breast Cancer Research and Treatment|April 28, 2025
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trialChristian Maurer, Elisa Agostinetto, Lieveke Ameye, et al.Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.Breast Cancer Research and Treatment|August 10, 2020
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory studyFrancesco Schettini, Navid Sobhani, Anna Ianza, et al.Oncotarget|June 23, 2014
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancerKatharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, et al.Frontiers in Oncology|February 6, 2023
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicineElisa De Paolis, Ida Paris, Bruno Tilocca, et al.Journal of the National Cancer Institute|December 1, 2021
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer PatientsMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.Pageof 32